CD8A and neoplasm: However, due to the aggressiveness of AE17-OVA+ tumors, antitumor immunity was overwhelmed – CD8+ T cells became exhausted, proliferative capacity, and persistence declined, accounting for the reduction in CD8+ T cells in the tumor.